5-chloro-1-(4-chlorophenyl)sulfonyl-3-(2-methoxyphenyl)-3-(4-pyridin-4-ylpiperazin-1-yl)indol-2-one
C30H26Cl2N4O4S — CID 68907053
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-chloro-1-(4-chlorophenyl)sulfonyl-3-(2-methoxyphenyl)-3-(4-pyridin-4-ylpiperazin-1-yl)indol-2-one
5-chloro-1-(4-chlorophenyl)sulfonyl-3-(2-methoxyphenyl)-3-(4-pyridin-4-ylpiperazin-1-yl)indol-2-one (PubChem CID 68907053) has the molecular formula C30H26Cl2N4O4S and a molecular weight of 609.54 g/mol. Its IUPAC name is 5-chloro-1-(4-chlorophenyl)sulfonyl-3-(2-methoxyphenyl)-3-(4-pyridin-4-ylpiperazin-1-yl)indol-2-one.
Molecular Properties
| Compound Name | 5-chloro-1-(4-chlorophenyl)sulfonyl-3-(2-methoxyphenyl)-3-(4-pyridin-4-ylpiperazin-1-yl)indol-2-one |
|---|---|
| PubChem CID | 68907053 |
| Molecular Formula | C30H26Cl2N4O4S |
| Molecular Weight | 609.54 g/mol |
| Exact Mass | 608.11 |
| IUPAC Name | 5-chloro-1-(4-chlorophenyl)sulfonyl-3-(2-methoxyphenyl)-3-(4-pyridin-4-ylpiperazin-1-yl)indol-2-one |
| SMILES | COc1ccccc1C1(N2CCN(c3ccncc3)CC2)C(=O)N(S(=O)(=O)c2ccc(Cl)cc2)c2ccc(Cl)cc21 |
| InChI | InChI=1S/C30H26Cl2N4O4S/c1-40-28-5-3-2-4-25(28)30(35-18-16-34(17-19-35)23-12-14-33-15-13-23)26-20-22(32)8-11-27(26)36(29(30)37)41(38,39)24-9-6-21(31)7-10-24/h2-15,20H,16-19H2,1H3 |
| InChIKey | YBNIXDLZRUDXGK-UHFFFAOYSA-N |
| XLogP | 5.20 |
| TPSA | 83.05 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 609.54 |
| LogP ≤ 5 | 5.20 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 68907053 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.